Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Neoplasms of the CNS

  Free Subscription


Articles published in J Natl Cancer Inst

Retrieve available abstracts of 18 articles:
HTML format
Text format



Single Articles


    March 2017
  1. WELLER M, Roth P, Sahm F, Burghardt I, et al
    Durable Control of Metastatic AKT1-Mutant WHO Grade 1 Meningothelial Meningioma by the AKT Inhibitor, AZD5363.
    J Natl Cancer Inst. 2017;109:1-4.
    PubMed     Text format     Abstract available


  2. NING J, Wakimoto H, Peters C, Martuza RL, et al
    Rad51 Degradation: Role in Oncolytic Virus-Poly(ADP-Ribose) Polymerase Inhibitor Combination Therapy in Glioblastoma.
    J Natl Cancer Inst. 2017;109:1-13.
    PubMed     Text format     Abstract available


    August 2016
  3. DEBEB BG, Lacerda L, Anfossi S, Diagaradjane P, et al
    miR-141-Mediated Regulation of Brain Metastasis From Breast Cancer.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format     Abstract available


    July 2016
  4. HOCHSTER HS, Sargent DJ
    One good DNA-damage deserves another: Oxaliplatin in MSI-high colon cancer.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format    


  5. TOUGERON D, Mouillet G, Trouilloud I, Lecomte T, et al
    Efficacy of Adjuvant Chemotherapy in Colon Cancer With Microsatellite Instability: A Large Multicenter AGEO Study.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format     Abstract available


    May 2016
  6. ZHANG C, Burger MC, Jennewein L, Genssler S, et al
    ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format     Abstract available


  7. SAHM F, Schrimpf D, Olar A, Koelsche C, et al
    TERT Promoter Mutations and Risk of Recurrence in Meningioma.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format     Abstract available


    February 2016
  8. BRASTIANOS PK, Shankar GM, Gill CM, Taylor-Weiner A, et al
    Dramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted Therapy.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format     Abstract available


  9. CHONG YK, Sandanaraj E, Koh LW, Thangaveloo M, et al
    ST3GAL1-Associated Transcriptomic Program in Glioblastoma Tumor Growth, Invasion, and Prognosis.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format     Abstract available


  10. ASKOXYLAKIS V, Ferraro GB, Kodack DP, Badeaux M, et al
    Preclinical Efficacy of Ado-trastuzumab Emtansine in the Brain Microenvironment.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format     Abstract available


  11. ZINDLER JD, Thomas CR Jr, Hahn SM, Hoffmann AL, et al
    Increasing the Therapeutic Ratio of Stereotactic Ablative Radiotherapy by Individualized Isotoxic Dose Prescription.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format     Abstract available


    November 2015
  12. SCHMIDT C
    Targeted Therapy Makes Inroads in Medulloblastoma.
    J Natl Cancer Inst. 2015;107.
    PubMed     Text format    


    August 2015
  13. YAN J, Kong LY, Hu J, Gabrusiewicz K, et al
    FGL2 as a Multimodality Regulator of Tumor-Mediated Immune Suppression and Therapeutic Target in Gliomas.
    J Natl Cancer Inst. 2015;107.
    PubMed     Text format     Abstract available


  14. COOKE JG
    RE: Germline Mutations in Shelterin Complex Genes Are Associated With Familial Glioma.
    J Natl Cancer Inst. 2015;107.
    PubMed     Text format    


  15. BAINBRIDGE M, Bondy ML
    Response.
    J Natl Cancer Inst. 2015;107.
    PubMed     Text format    


  16. JENSEN TW, Ray T, Wang J, Li X, et al
    Diagnosis of Basal-Like Breast Cancer Using a FOXC1-Based Assay.
    J Natl Cancer Inst. 2015;107.
    PubMed     Text format     Abstract available


    June 2015
  17. CONSONNI D, Pierobon M, Gail MH, Rubagotti M, et al
    Lung cancer prognosis before and after recurrence in a population-based setting.
    J Natl Cancer Inst. 2015;107.
    PubMed     Text format     Abstract available


    May 2015
  18. GUPTA SK, Kizilbash SH, Carlson BL, Mladek AC, et al
    Delineation of MGMT Hypermethylation as a Biomarker for Veliparib-Mediated Temozolomide-Sensitizing Therapy of Glioblastoma.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: